The results revealed that TPP1 was also overexpressed in several other cancers, such as esophageal carcinoma, stomach adenocarcinoma, and liver hepatocellular carcinoma, and increased expression of TPP1 was associated with worse survival in these cancers (S3 Fig). Here, TPP1 is linked to carcinoma of esophagus.